EE95 Cost-Effectiveness Analysis of Pemigatinib for the Treatment of Adult Patients with Locally Advanced or Metastatic Cholangiocarcinoma with a FGFR2 Fusion or Rearrangement That Have Progressed After Systemic Therapy in Greece

Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.366
https://www.valueinhealthjournal.com/article/S1098-3015(23)03496-4/fulltext
Title : EE95 Cost-Effectiveness Analysis of Pemigatinib for the Treatment of Adult Patients with Locally Advanced or Metastatic Cholangiocarcinoma with a FGFR2 Fusion or Rearrangement That Have Progressed After Systemic Therapy in Greece
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03496-4&doi=10.1016/j.jval.2023.09.366
First page :
Section Title :
Open access? : No
Section Order : 12391
Categories :
Tags :
Regions :
ViH Article Tags :